PTAB Reverses Course and Finds Challenged Patent Claims Unpatentable in Light of Applicant Admitted Prior Art

Dec 2, 2022

Reading Time : 2 min

Petitioner’s obviousness grounds in the IPR relied on one or more prior art references in combination with AAPA, which included admissions in the specification of the challenged patent about prior art photo voltaic systems. Relying on a Guidance Memo from the USPTO Director, a PTAB panel found that because the petition relied on AAPA, and therefore did not rely on patents and printed publications to teach all the limitations, petitioner had not shown that the challenged claims were unpatentable.

Petitioner filed a request for rehearing and argued that its use of AAPA was consistent with the Director’s Updated Guidance, which states that “[i]f an IPR petition relies on admissions in combination with reliance on one or more prior art patents or printed publications, those admissions do not form ‘the basis’ of the ground and must be considered by the Board in its patentability analysis.” In opposition, patent owner argued that petitioner’s use of AAPA in this proceeding was not proper because “it forms the basis of Petitioner’s arguments” and because “there is no evidence that the asserted AAPA was known in the prior art.” The PTAB panel sided with petitioner and in doing so explained that “AAPA is not the basis of this inter partes review proceeding” because the grounds “involve a combination of AAPA and prior art patents(s),” where the “AAPA is being properly used to supply the missing claim limitation.” In support of this finding, the PTAB panel stated that the Federal Circuit “has held ‘it is appropriate to rely on admissions in a patent’s specification when assessing whether that patent’s claims would have been obvious’ in an inter partes review proceeding” (quoting Qualcomm, Inc. v. Apple, Inc., 24 F.4th 1367, 1375 (Fed. Cir. 2022)). After considering petitioner’s AAPA, the PTAB panel determined that the challenged claims were unpatentable.

Notably, in finding the claims unpatentable, the PTAB disregarded patent owner’s argument that there was “no evidence that the asserted AAPA was generally known in the prior art or was within the knowledge of an ordinarily-skilled artisan at the time of the invention.” Petitioner challenged the board’s consideration of this argument because patent owner did not make this argument in either its Response or Sur-Reply. Instead, it waited until the hearing to “re-characterize its admissions” to say that the AAPA was only known to the applicant, and was not known to a person of ordinary skill in the art. Here, the PTAB agreed with petitioner and did not consider patent owner’s argument because “no new arguments” can be made at an oral hearing.

Practice Tip: Petitioners and patent owners in IPR proceedings should remain vigilant regarding the use of AAPA before the PTAB. AAPA can play a critical role in the ultimate determination by the board regarding the patentability of challenged claims. Under the PTAB’s current guidance, AAPA may be properly used in combination with prior art patents and publications in order to provide missing limitations. But AAPA cannot alone form the basis of any ground in an IPR.

Solaredge Tech. Ltd. v. SMA Solar Tech. AG, IPR2020-00021, Paper 31 (PTAB October 25, 2022).

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.